Doctor profile · Federal record
Dr. KASHIF ALI, M.D.
Hematology & Oncology Physician (CMS: INTERNAL MEDICINE) · Internal Medicine Physician · Internal Medicine Physician · Hematology & Oncology Physician · SILVER SPRING, MD
- NPI 1851423388
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 24 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
11886 HEALING WAY STE 701
SILVER SPRING, MD 209047917
(301) 933-3216
fax (832) 601-6868 - Additional location
-
7140 Contee Rd Ste 3500
Laurel, MD 207079536 - Mailing address
-
10710 CHARTER DR STE G020
COLUMBIA, MD 210443257
Credentials & registration
- NPI registered
- March 2007 — 19 yrs on file
- Profile last updated
- May 8, 2025
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Maryland #D69297 · New Jersey #25MA08010900
- Medicaid
- NJ #0130184
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851423388. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
462,190
Distinct HCPCS
10
Medicare allowed
$4,532,220
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 119,150 | 107 | $3 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 113,250 | 69 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 37,000 | 19 | $30 | |
J1756 |
Injection, iron sucrose, 1 mg | 34,700 | 52 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 23,940 | 126 | $23 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 21,000 | 12 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 16,700 | 16 | $50 | |
J0185 |
Injection, aprepitant, 1 mg | 14,690 | 28 | $2 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 14,520 | 20 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 12,060 | 13 | $47 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 3,889. This provider delivers 119× the peer median.Open Payments
Industry payments received
All-time total
$221,790
Transactions
241
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 24 | $54,550.32 | |
| AstraZeneca Pharmaceuticals LP | 42 | $47,727.73 | |
| Regeneron Healthcare Solutions, Inc. | 36 | $36,323.22 | |
| SOBI, INC | 18 | $35,004.92 | |
| E.R. Squibb & Sons, L.L.C. | 33 | $33,492.27 | |
| BeiGene USA, Inc. | 3 | $4,534.84 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $2,887.01 | |
| PFIZER INC. | 18 | $1,923.98 | |
| Novartis Pharmaceuticals Corporation | 32 | $1,495.46 | |
| Adaptive Biotechnologies Corporation | 1 | $1,050.00 | |
| Celgene Corporation | 4 | $368.11 | |
| Janssen Biotech, Inc. | 14 | $271.73 | |
| Cardinal Health 110 LLC | 1 | $250.00 | |
| Daiichi Sankyo Inc. | 7 | $234.86 | |
| Lilly USA, LLC | 5 | $172.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
848
Patients
148
Total drug cost
$708,438
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 272 | 52 | $189,443 |
| Letrozole | Generic | 114 | 36 | $3,233 |
| Oxycodone Hcl | Generic | 52 | 0 | $2,277 |
| Ondansetron Hcl | Generic | 45 | 20 | $1,060 |
| Xarelto (Rivaroxaban) | Brand | 44 | 0 | $48,268 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 42 | 11 | $1,132 |
| Anastrozole | Generic | 38 | 12 | $1,674 |
| Hydroxyurea | Generic | 33 | 0 | $1,219 |
| Warfarin Sodium | Generic | 33 | 0 | $577 |
| Dexamethasone | Generic | 32 | 17 | $829 |